Renaissance Technologies LLC raised its stake in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 7.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,761,666 shares of the company’s stock after buying an additional 128,766 shares during the period. Renaissance Technologies LLC owned 7.05% of USANA Health Sciences worth $101,472,000 at the end of the most recent quarter.
A number of other hedge funds have also bought and sold shares of the stock. Victory Capital Management Inc. boosted its stake in USANA Health Sciences by 124.7% in the first quarter. Victory Capital Management Inc. now owns 2,117 shares of the company’s stock worth $122,000 after buying an additional 1,175 shares during the last quarter. Focused Wealth Management Inc boosted its stake in USANA Health Sciences by 279.9% in the fourth quarter. Focused Wealth Management Inc now owns 2,112 shares of the company’s stock worth $129,000 after buying an additional 1,556 shares during the last quarter. Nine Chapters Capital Management LLC acquired a new stake in USANA Health Sciences during the first quarter worth approximately $207,000. Trexquant Investment LP acquired a new stake in USANA Health Sciences during the fourth quarter worth approximately $220,000. Finally, HPM Partners LLC acquired a new stake in USANA Health Sciences during the first quarter worth approximately $268,000. 44.26% of the stock is owned by institutional investors and hedge funds.
Shares of USANA Health Sciences, Inc. (NYSE:USNA) traded down 1.92% on Tuesday, hitting $63.75. The stock had a trading volume of 49,090 shares. The stock has a market capitalization of $1.56 billion, a P/E ratio of 16.09 and a beta of 1.10. USANA Health Sciences, Inc. has a 52 week low of $52.55 and a 52 week high of $75.00. The firm has a 50-day moving average price of $63.85 and a 200-day moving average price of $60.63.
USANA Health Sciences (NYSE:USNA) last announced its earnings results on Tuesday, May 2nd. The company reported $0.91 EPS for the quarter, missing analysts’ consensus estimates of $0.92 by $0.01. The firm had revenue of $255.32 million for the quarter. USANA Health Sciences had a net margin of 8.37% and a return on equity of 25.23%. Equities analysts expect that USANA Health Sciences, Inc. will post $3.95 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “Renaissance Technologies LLC Has $101.47 Million Position in USANA Health Sciences, Inc. (USNA)” was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this piece can be viewed at https://sportsperspectives.com/2017/06/20/renaissance-technologies-llc-buys-128766-shares-of-usana-health-sciences-inc-usna-updated.html.
USNA has been the topic of a number of research reports. Zacks Investment Research upgraded USANA Health Sciences from a “sell” rating to a “hold” rating in a research note on Wednesday, April 12th. Pivotal Research restated a “hold” rating and issued a $55.00 price objective (down from $75.00) on shares of USANA Health Sciences in a research note on Monday, May 1st. Finally, BidaskClub raised USANA Health Sciences from a “hold” rating to a “buy” rating in a report on Tuesday, June 13th.
In other news, Director Myron W. Wentz sold 40,000 shares of the stock in a transaction on Wednesday, April 5th. The stock was sold at an average price of $56.81, for a total value of $2,272,400.00. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Paul A. Jones sold 9,851 shares of the stock in a transaction on Thursday, June 1st. The shares were sold at an average price of $64.50, for a total value of $635,389.50. Following the completion of the sale, the insider now owns 6,020 shares in the company, valued at $388,290. The disclosure for this sale can be found here. Insiders sold 174,735 shares of company stock valued at $10,349,724 over the last 90 days. Company insiders own 53.20% of the company’s stock.
About USANA Health Sciences
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.